Henry Joseph Horacek

Title: The Innovations of Henry Joseph Horacek

Introduction

Henry Joseph Horacek is an accomplished inventor based in Charlotte, NC. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of adrenergic dysregulation. His innovative approach has led to the development of a unique formulation that addresses this medical condition effectively.

Latest Patents

Horacek holds a patent for an "Extended release formulation and method of treating adrenergic dysregulation." This patent describes a composition and method for treating adrenergic dysregulation by administering a formulation that includes a2-adrenergic receptor agonist, a pharmaceutically acceptable hydrophilic matrix, and a release-retardant of a metal alkyl sulfate. The composition is designed to provide a sustained release of the agonist, ensuring that the plasma concentration peak-to-trough ratio remains no greater than about 1.9 after administration.

Career Highlights

Horacek is currently employed at Shionogi Pharma, Inc., where he continues to innovate and develop new pharmaceutical solutions. His work has been instrumental in advancing treatment options for patients suffering from adrenergic dysregulation. With a focus on improving patient outcomes, he has dedicated his career to research and development in the pharmaceutical industry.

Collaborations

Some of his notable coworkers include Min Michael He and Moise A Khayrallah. Their collaborative efforts contribute to the innovative environment at Shionogi Pharma, Inc., fostering advancements in pharmaceutical research.

Conclusion

Henry Joseph Horacek's contributions to the field of pharmaceuticals, particularly through his patent on adrenergic dysregulation treatment, highlight his role as a significant inventor. His work continues to impact the medical community positively, showcasing the importance of innovation in healthcare.